The Dividend Freedom Tribe's model portfolios have outperformed the S&P 500 year to date, although they experienced significant underperformance in September. This dip highlights a key risk that dividend investors must address to protect their portfolios. The group focuses on helping everyday investors build sustainable wealth through strategic dividend investing, offering three model portfolios tailored to different investment styles. Members gain access to exclusive stock analysis, buy/sell recommendations, and a supportive community aimed at achieving financial independence.
The Elephant In The Room For Dividend Investors offers context for readers interested in market trends. For readers following US stocks on Pluang, here is the market snapshot as of Nov 14, 2026 00:11 WIB: Out of 150 priced stocks, 74 rose and 75 fell. Among notable movers, AMD dropped 10.20% to USD 525.59 with a typical hold time of 93 days, contrasting with Lucid Group Inc (LCID) which fell 7.68% to USD 3.00 but saw 100% buy orders and a shorter hold time of 46 days. Plug Power Inc (PLUG) declined 8.91% to USD 1.12, yet had a strong buy interest at 78% with a 43-day hold time.
Susan R. Burns, Ph.D., President of the University of Mount Saint Vincent, has been awarded the 2027 Courageous Leadership Award for her visionary and bold leadership. Since 2021, she has led the university through significant transformation, includi...
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...
